Continuum Rt V12 Free Download
Fatima Rubalcava
The HIV care continuum is a public health model that outlines the steps or stages that people with HIV go through from diagnosis to achieving and maintaining viral suppression (a very low or undetectable amount of HIV in the blood) through care and treatment with HIV medicine called antiretroviral therapy or ART.
The HIV care continuum is useful both as an individual-level tool to assess care outcomes, as well as a population-level framework to analyze the proportion of people with HIV in a given community who are engaged in each successive step. This helps policymakers and service providers better pinpoint where gaps in services might exist and develop strategies to better support people with HIV to achieve the treatment goal of viral suppression.
Diagnosis-based continuum. Different analyses present the steps or stages of the HIV care continuum in different ways. For example, CDC also offers a diagnosis-based continuum, which shows each step as a percentage of the number of people with diagnosed HIV. According to CDC data published in 2022, of the 944,247 people ages 13 and older with diagnosed HIV in the U.S. during 2020, 74% had received some HIV medical care, 51% were retained in care, and 65% were virally suppressed. In addition, among the 28,422 individuals who received an HIV diagnosis in 2020 in the 46 jurisdictions with complete reporting of laboratory data to CDC, 82% were linked to medical care within one month of diagnosis. (CDC cautions that data for 2020 should be interpreted with caution due to the impact of COVID-19 on access to HIV testing, care-related services, and case surveillance activities in states and local jurisdictions.) (Read about the diagnosis-based approach to monitoring the HIV care continuum.)
Federal, state, and local health departments, community-based organizations, health care providers, and people with HIV continue to use the HIV care continuum to measure progress toward HIV goals as well as to pinpoint where gaps in services may exist in connecting individuals with HIV to sustained, quality care and treatment. Knowing where drop-offs are most pronounced and for which populations helps policymakers, public health officials, and health care providers implement system improvements to support all persons with HIV so they are able to successfully navigate the continuum and achieve and maintain viral suppression.
For both inherited and de novo ASD risk factors, the team found strong links between genetic influences on ASD and social/behavioral trait differences in the general population. These findings suggest that the genetic risk underlying ASD influences a continuum of behavioral and developmental traits across the population, with those diagnosed with ASD representing a severe presentation of those traits. The findings also support the observation that some family members of people with ASDs are more likely to manifest social and communication traits that are closer to those associated with ASD since family members carry, on average, an increased genetic risk for ASD. This tendency is similar to that observed in the familiality of height: extremely tall individuals often have family members of above average height themselves.
760c119bf3